American Thyroid Association

Business news, market intelligence, and global industry analysis.

The Latest

What the latest UTOPIA trial data reveal about UGN-103’s competitive position in LG-IR-NMIBC

Delivery Hero (DHER) stock up 4% to €29.5 as Aspex forces CEO exit and Korea sale opens

What the RIDGE-1 interim results reveal about the future of cardiac gene therapy in ARVC

Hanwha Aerospace targets NATO demand with Romania unmanned systems push at BSDA 2026

Can plixorafenib redefine thyroid cancer treatment? Inside FORE Biotherapeutics’ latest trial results

FORE Biotherapeutics reveals ATA 2025 data showing plixorafenib’s long-lasting effects in BRAF-altered thyroid cancers. See why it’s generating investor buzz.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures

September 13, 2025